MedPath

A clinical trial to study the comparative effect of two doses of nebulised dexmedetomidine on vital parameters ( Blood pressure and heart Rate) during General anaesthesia in adults

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/04/042063
Lead Sponsor
Jyoti kanwat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 The patients of either sex in the age group of 18 to 60 years with American Society of Anesthesiologists Physical Status I and II undergoing elective surgery under general anaesthesia.

Exclusion Criteria

1Patients who are not giving consent

2Patients with ASA III and ASA IV

3Patients with anticipated difficult intubation.

4Pregnant patient

5Patient with body mass index > 30 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the two doses of nebulised dexmedetomidine as premedication on hemodynamic response to laryngoscopy and intubation reflex.Timepoint: 24 weeks
Secondary Outcome Measures
NameTimeMethod
1.To measure post nebulization sedation <br/ ><br>2.To determine the post-op sore throat <br/ ><br>Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath